The cardiac marker market analysis focuses on high-sensitivity assays (hs-Cardiac Troponin) and multiplex biomarker panels.

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, introduces the Next-Generation Basophil Activation Test (BAT) for research use only to more effectively ...

The first blood test to help diagnose Alzheimer’s disease will be available from late June in the US following regulatory ...

Introducing the new Allegra X-14 Series. At 120 volts, it's a great alternative to the higher voltage Allegra X-15R. This benchtop centrifuge is convenient, hardworking, reliable, and will speed ...

What will become of the sprawling Beckman Coulter campus in Brea? The 34-acre site at 200 and 250 S. Kraemer St. is up for grabs, listed by Cushman & Wakefield for “an unlisted price ...

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of the OptiMATE Gradient Maker, a groundbreaking instrument ...

BREA, Calif., March 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry ...

A broad menu of high quality assays from Beckman Coulter, plus new, productivity-enhancing features on the Access 2 offer laboratories a flexible option for immunoassay testing.

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Beckman Coulter Diagnostics' new DxC 500i Clinical ...

An office and industrial campus once occupied by biotechnology research company Beckman Coulter Diagnostics has hit the open market. Houston-based real estate company Hines hired Cushman & Wakefield ...

The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...